Cargando…
Crescentic IgA nephropathy along with simultaneous cellular and antibody‐mediated rejection in a kidney transplant leading to rapid allograft failure
Crescentic IgA Nephropathy in a renal transplant can lead to rapid loss of graft function despite treatment. Concurrent treatment‐resistant acute cellular and antibody‐mediated rejection make the prognosis even worse.
Autores principales: | Gani, Imran, Kleven, Daniel, Mulloy, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745376/ https://www.ncbi.nlm.nih.gov/pubmed/31534747 http://dx.doi.org/10.1002/ccr3.2364 |
Ejemplares similares
-
De-Novo Focal Crescentic IgA Nephropathy in a Renal Allograft Recipient
por: Ramasamy, Ashok, et al.
Publicado: (2019) -
Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021) -
Crescents and IgA Nephropathy: A Delicate Marriage
por: Trimarchi, Hernán, et al.
Publicado: (2022) -
TWEAK/Fn14 system and crescent formation in IgA nephropathy
por: Sasaki, Yohei, et al.
Publicado: (2015) -
Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?
por: Ring, Troels, et al.
Publicado: (2015)